SCHEMBL27384456

SCHEMBL27384456

CC(C)c1cc2[nH]c(CNC(=O)N3CCCC3O)cc2cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.37
▸ AADAT Q8N5Z0 3/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ HRH3 Q9Y5N1 2/20 0.36
▸ MAPK1 P28482 1/20 0.35
▸ TACR1 P25103 2/20 0.34
▸ MTNR1A P48039 2/20 0.33
▸ MTNR1B P49286 2/20 0.33
▸ POLB P06746 1/20 0.33
▸ EPHX2 P34913 1/20 0.33
▸ SLC2A1 P11166 1/20 0.32
▸ PTGES O14684 1/20 0.32
▸ AVPR2 P30518 1/20 0.32
▸ F2R P25116 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27384451 0.90 AADAT (0.38) RAB9AAADATSMN1; SMN2HRH3MAPK1
SCHEMBL27384854 0.83 MAPK1 (0.41) RAB9ASMN1; SMN2HRH3MAPK1POLB
SCHEMBL27383269 0.79 RAB9A (0.56) RAB9ASMN1; SMN2MTNR1AMTNR1BPOLB
SCHEMBL27385164 0.78 RAB9A (0.41) RAB9ASMN1; SMN2MTNR1AMTNR1BMEN1
SCHEMBL27384349 0.78 SMN1; SMN2 (0.38) RAB9ASMN1; SMN2HRH3MAPK1EPHX2
SCHEMBL27385039 0.78 RAB9A (0.42) RAB9ASMN1; SMN2MTNR1AMTNR1BMEN1
SCHEMBL27384178 0.77 SMN1; SMN2 (0.42) RAB9ASMN1; SMN2POLBMEN1KMT2A
SCHEMBL27385036 0.76 RAB9A (0.43) RAB9ASMN1; SMN2MTNR1AMTNR1BMEN1
SCHEMBL27385903 0.76 SMN1; SMN2 (0.50) RAB9ASMN1; SMN2MAPK1MTNR1AMTNR1B
SCHEMBL27382675 0.75 MTNR1A (0.44) RAB9ASMN1; SMN2MTNR1AMTNR1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024081748-A2 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback